ÀÏ×ÓÓÐÇ®lzyq88¹ÙÍø

À´Ô´£º¿ÚÇ»¿ÆÐ¡ÍƳµ £¬×÷Õߣº »¯·Ê £¬£º

°¥ £¬ÎÒ¸úÄ㽲࣠£¬¹ãÖÝÀóÍåÇøÄÇ¿éµØ·½Å¶ £¬²Ø×Ų»ÉٺóԺÃÍæµÄ°å·¡£ÄãÏþµÃû £¬ÓÐЩ½ÖµÀÃû×ÖÌýÆð¾ÍÂùÓÐÒâ˼ £¬ºÃ±ÈÓеĵط½Ö±½ÓÓÃÍâµØÌØÉ«ÃüÃû £¬ÏñÊǼ¦½ÖÕâÖÖ¡£ÎÒ¹À¶ÑÐí¶àÈ˶¼ºÃÆæ £¬Õ⼦½Ö¾¿¾¹¸ü×ÓÀ´µÄ  £¿Ãû×Ö±³ºóÊDz»ÊÇÁíÓеã¹ÊÊ  £¿½ñÌìÎÒÃǾÍÀ´³¶³¶ÀóÍåÇøµÄСºúͬ¼¦½Ö £¬Þß¿­¾¿¾¹½Ðɶ £¬½²Î´±ØÄ㻹ÄÜ·¢Ã÷µãÐÂÏʰåÂ·ÄØ¡£

ÀóÍåÇøÐ¡ºúͬ¼¦½ÖµÄÃû×ÖÀ´Àú

Ïà¹ØÍ¼Æ¬

Õâô¸úÄã½²¿© £¬ÀóÍåÇøÐ¡ºúͬ¼¦½ÖÆäʵÂùÓÐȤµÄ¡£ËüÃû×ֽм¦½Ö £¬ÓÐÈËÒ»Ìý¾ÍÒÔΪÊÇÂô¼¦µÄµØ·½ £¬ÆäʵÞß¿­Ö÷ÒªÊDzÍÒûÒ»Ìõ½Ö £¬ÓÈÆäÒÔ¼¦µÄÖÖÖÖ×ö·¨×ÅÃû¡£Ïñ°×Çм¦¡¢ÉÕ¼¦ÕâЩ £¬ÏÕЩÊǼҼҶ¼ÓеÄÕÐÅÆ²Ë¡£ÎÒ´ÓϸÍÞ×оÍÌý˵ £¬¼¦½ÖÃû×ÖµÄÓÉÀ´ £¬¿ÉÄÜÊÇ×îÔçÄÇ¿­Óм¸¼Ò×ö¼¦µÄ¹Ý×Ó £¬ÉúÒâºÃµÃ°å· £¬ÕûÌõ½Ö¶¼Ëæ×ÅÍúÆðÀ´ÁË¡£

½²µ½ÕâÀï £¬Äã·¢Ã÷û £¬ÕâÖÖ¡°ÒÔ¼¦ÎªÃû¡±µÄ½ÖµÀ £¬Æäʵ¾ÍÊÇÒ»ÖÖÀϹãÖݵÄÎÄ»¯ÌØÉ«¡£ÓÃʳÎïÀ´±ê¼ÇµØÃû £¬¼È¼òµ¥ÓÖÖ±½Ó¡£Ïñ¹ðÁÖÎÒÃÇÕâ±ßÒ²ÓÐÃ×·Û½Ö £¬¶¼ÊDzîδ¼¸µÄ°å·¡£

ʵÓÃСÌùÊ¿£º¼¦½ÖÔõô¿Ë²»²È¿Ó  £¿

ʵÓÃСÌùÊ¿£ºÞß¿­µÄ¹Ý×Ó¶à £¬¼ÇµÃÑ¡ÄÇЩÃÅ¿ÚÈËÆøÍúµÄ £¬ÓÈÆäÊÇÍâµØÈ˰®È¥µÄµê×Ó £¬Ò»°ãζµÀ¶¼´í²»ÁË¡£ÁíÍâ £¬¼°ÔçÈ¥ £¬Ã»È»Íí·¹á¯ÁëÈ˼·ÈË £¬ÅŶÓÅŵ½ÄãÏë¡°·¢Ã«¡±¡£

¼¦½ÖµÄÌØÉ«²ËºÍÎÄ»¯Æø·Õ

ÔÙ½²»Ø¼¦½ÖµÄÌØÉ«²Ë £¬ÎÒ¹À¶Ñ×î×ÅÃûµÄÕվɰ×Çм¦ £¬ÈâÄ۵ðå· £¬ÕºÉϽª´Ð½´ÓÍ £¬Ë¬ÉñµÃºÜ¡£ÁíÍâÉÕ¼¦Ò²ÊÇÒ»¾ø £¬Æ¤ËÖÈâÏã £¬Ò§ÉÏÒ»¿Ú¼òֱͣ²»ÁË¡£³ýÁ˼¦ £¬Þß¿­ÁíÓв»ÉÙÔÁ²ËÉϵÄСµãÐÄ £¬ºÃ±ÈϺ½È¡¢³¦·ÛÕâЩ £¬´îÅäÆðÀ´ £¬¼òÖ±¾ÍÊÇÒ»×À×Ó¹ãÖÝζ¡£

³ýÁË³ÔµÄ £¬¼¦½ÖµÄÎÄ»¯Æø·ÕÒ²ÓеãÒâ˼¡£½ÖµÀ²»¿í £¬Ïï×ÓÀïÍ·¼·ÂúÁËʳ¿Í £¬ÉÌÆÌµÄÕÐÅÆÒ»¸ö°¤Ò»¸ö £¬µÆ×ÆË¸µÃ»ÐÄ£ºý㱡£ÄãÏþµÃû £¬ÓÐʱºò³ÔµÄ²»ÊÇ²Ë £¬ÊÇÕâÖÖÈÈÄÖÆø·Õ £¬Ò»±ßࢼ¦Ò»±ßÌýÀϰåÕкô¿ÍÈË £¬¸ÐÊܳԳöÁËÈËÇéζ¡£

³£¼ûÎóÇø£º¼¦½ÖÖ»³Ô¼¦  £¿

³£¼ûÎóÇø£ºÓÐÈËÒÔΪ¼¦½ÖÖ»ÄܳԼ¦ £¬ÆäʵÞß¿­µÄÔÁ²ËÒ²Âù¸»ºñµÄ £¬Ïñº£ÏÊ¡¢µãÐÄÕâЩ¶¼ÖµµÃÊÔÊÔ¡£Äª¾ÖÏÞÓÚ¼¦ £¬Õû×ÀµãÆðÀ´²Å¸üˬÉñ¡£
Ïà¹ØÍ¼Æ¬

ÄǾ¿¾¹Òª¸ü×ÓÑ¡²Åû²È¿Ó  £¿

ÎÒ¹À¶ÑŶ £¬¼¦½ÖÑ¡¹Ý×ÓÖ÷Òª¿´ÈËÆø £¬Ñ¡ÍâµØÈËÔú¶ÑµÄµØ·½×¼Ã»´í¡£ÔټǵÃÔçµãÈ¥ £¬Ã»È»ÅŶÓÅŵ½Í·»è¡£³ÔµÄʱºò±ðÖ»¶¢×ż¦ £¬µãµãÆäËûÔÁ²ËºÍСµãÐÄ £¬´îÅäÆðÀ´¸ü°ÍÊÊ¡£

ÀóÍåÇø¼¦½Ö, ¹ãÖÝÃÀʳ½Ö, ¼¦½Ö²Í¹ÝÍÆ¼ö, °×Çм¦, ÔÁ²ËÌØÉ«

¡¶³É¶¼ÄÄÀïÕ¾´ó½Ö×îÄêÇá¡·

ËüÃǵÄÐж¯±êÃ÷ £¬Ç¿´óµÄ±¾ÍÁ¹©Ó¦Á´Ð­Í¬³öº£ £¬ÎªÖйú¿¨³µÆ·ÅÆÌṩÁ˱¾Ç®¡¢ÏìÓ¦ËٶȺͼ¼Êõ¶¨ÖÆÉÏµÄÆæÌؼ¯ÍžüÓÅÊÆ £¬ÊÇÕû³µ³§ÔÚǰÏß³å·æÊ±×î¿É¿¿µÄ¡°µ¯Ò©ÓëºóÇÚ°ü¹Ü¡±¡£

¡¶ËÄÖÜÍÆÄõê500Ã×ÄÚÓÐÄÄЩ¡·

About U-mab U-mab Biopharma,founded in July2017,is a biotechnology company focused on discovering and developing NOVel First-in-class(FIC)and best-in-class(BIC)biologic therapeutics for oncology and inflammatory diseases.The company received a strategic investment from Tianhui Capital in2021and has established a fully integrated,proprietary platform for early-stage antibody discovery and engineering¡ªenabling the rapid identification and optimization of high-quality therapeutic candidates.Guided by a core Strategy of inNOVation-driven internal RD,U-mab actively pursues strategic collaborations with industry leaders to advance its pipeline toward clinical development.

¡¶ÉîÛÚspa»çËØÒ»ÀÀ±í¡·

ËäÈ»ÌØÀÊÆÕ¹ØÓÚÊÕ¹º¸ñÁêÀ¼µºµÄÑÔÂÛ²¢·ÇÐÂÏÊÊ¡ª¡ª¿É×·ËÝÖÁ2019ÄêËûµÄµÚÒ»¸öÈÎÆÚ¡ª¡ªµ«Æä½üÆÚµÄÑÔÂÛÇ¿¶ÈÓÐËùÉý¼¶ £¬²¢Îª×Ô¼ºÉ趨ÁËÁ½µ½ÈýÖܵÄ×îºóÆÚÏÞÒÔÈ¡µÃ½øÕ¹¡£ÕâÖÖÔÙ¶ÈÉýεÄÐж¯ÐźűêÃ÷ £¬ÌØÀÊÆÕ¶Ô¸ñÁêÀ¼µØÔÃ÷ÈÕ½ÂÔ¼ÛÖµµÄºã¾ÃÐËȤ £¬ÓëÆäËùÈÏÖªµÄÈ«ÇòÍþв֮¼ä±£´æÒò¹û¹ØÁª¡£

ÍøÕ¾µØÍ¼